Mary Kay To Pay $40M Over Wrinkle Cream Patent

Law360, New York (April 6, 2006, 12:00 AM EDT) -- Makeup retailer Mary Kay Inc. has been orderd by a jury to pay TriStrata Technology Inc. $40 million for allegedly infringing patents for its skin care remedy used to treat wrinkles.

TriStrata, a subsidiary of NeoStrata Co., originally filed the lawsuit in 2001, accusing Mary Kay of using its patented alpha hydroxy acid technology.

In March 2005, a jury ordered Mary Kay to pay more than $26 million in backend royalties to Delaware-based TriStrata. TriStrata returned to court to seek interest on that amount.

The total...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.